1. Mond, H. G., & Proclemer, A. (2011). The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009—a world society of arrhythmia’s project. PACE, 34, 1013–1027.
2. Feigal, D. W., Gardner, S. N., & McClellan, M. (2003). Ensuring safe and effective medical devices. The New England Journal of Medicine, 348(3), 191–192.
3. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). (1998). Guidance for Industry Providing Clinical Evidence of Effectiveness for Human Drug and Biological Products. Rockville: CDER and CBER.
4. Garber, A. M. (2010). Modernizing device regulation. The New England Journal of Medicine, 362(13), 1161–1163.
5. Food, Drug, and Cosmetic Act. 21 USC § 201(h). http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/ . Accessed 19 Nov 2012.